YAP1 and cancer: Activating mutations in YAP and TAZ are extremely uncommon in human cancer [54, 61, 66], and individual activation mutations of YAP and TAZ are insufficient to induce tumorigenesis, which may be related to the negative feedback loop associated with YAP and TAZ [67].